The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Interleukin‐17–positive mast cells contribute to synovial inflammation in spondylarthritis
Abstract
Objective: Studies comparing spondylarthritis (SpA) to rheumatoid arthritis (RA) synovitis suggest that innate immune cells may play a predominant role in the pathogenesis of SpA. Recent observations have indicated a marked synovial mast cell infiltration in psoriatic SpA. We therefore undertook the present study to investigate the potential contribution of mast cells to synovial inflammation in SpA. Methods: Synovial tissue and fluid were obtained from patients with either nonpsoriatic or psoriatic SpA (n = 82) and patients with RA (n = 50). Synovial biopsy tissue was analyzed by immunostaining and used in ex vivo cultures. Synovial fluid was analyzed by enzyme‐linked immunosorbent assay. Results: We observed a strong and specific increase of c‐Kit–positive mast cells in the synovium from patients with SpA compared to the synovium from patients with RA synovitis, which was independent of disease subtype (nonpsoriatic versus psoriatic), disease duration, and treatment. Staining of mast cell granules, analysis of synovial fluid, and results in ex vivo tissue culture did not indicate increased degranulation in SpA synovitis. However, mast cells expressed significantly more interleukin‐17 (IL‐17) in SpA than in RA synovitis, and mast cells constituted the major IL‐17–expressing cell population in the SpA synovium. Ex vivo targeting of synovial mast cells with the c‐Kit inhibitor imatinib mesylate significantly decreased the production of IL‐17 as well as other proinflammatory cytokines in synovial tissue cultures. Analysis of paired pre‐ and posttreatment synovial tissue samples indicated that the mast cell/IL‐17 axis in SpA was not modulated by effective tumor necrosis factor (TNF) blockade. Conclusion: The specific and TNF‐independent increase in IL‐17–expressing mast cells may contribute to the progression of synovial inflammation in peripheral SpA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,752
Revised Criteria for the Classification of Rheumatoid Arthritis
Arnett, F. C. (1990) · Orthopaedic Nursing · doi:10.1097/00006416-199003000-00011 · Cited by 7,723
Taylor, W., Gladman, D., Helliwell, P., Marchesoni, A., Mease, P., & Mielants, H. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21972 · Cited by 3,746
Dougados, M., Linden, S. V. D., Juhlin, R., Huitfeldt, B., Amor, B., Calin, A., Cats, A., Dijkmans, B., Olivieri, I., Pasero, G., et al. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780341003 · Cited by 2,299
Mast cells in the development of adaptive immune responses
Galli, S. J., Nakae, S., & Tsai, M. (2005) · Nature Immunology · doi:10.1038/ni1158 · Cited by 1,279
Mast Cells: A Cellular Link Between Autoantibodies and Inflammatory Arthritis
Lee, D. M., Friend, D. S., Gurish, M. F., Benoist, C., Mathis, D., & Brenner, M. B. (2002) · Science · doi:10.1126/science.1073176 · Cited by 750
IL-33 exacerbates antigen-induced arthritis by activating mast cells
Xu, D., Jiang, H.-R., Kewin, P., Li, Y., Mu, R., Fraser, A. R., Pitman, N., Kurowska-Stolarska, M., McKenzie, A. N. J., McInnes, I. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801898105 · Cited by 464
Cutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells
Allakhverdi, Z., Smith, D. E., Comeau, M. R., & Delespesse, G. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2051 · Cited by 431
Differential release of mast cell mediators and the pathogenesis of inflammation
Theoharides, T. C., Kempuraj, D., Tagen, M., Conti, P., & Kalogeromitros, D. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00519.x · Cited by 425
Mast cells and angiogenesis: Review article
Norrby, K. (2002) · APMIS · doi:10.1034/j.1600-0463.2002.100501.x · Cited by 381
Cited by
Targeting IL-17 and TH17 cells in chronic inflammation
Miossec, P., & Kolls, J. K. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3794 · Cited by 1,414
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
Baeten, D., Sieper, J., Braun, J., Baraliakos, X., Dougados, M., Emery, P., Deodhar, A., Porter, B., Martin, R., Andersson, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1505066 · Cited by 1,029
Self-citationThe Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
Blauvelt, A., & Chiricozzi, A. (2018) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-018-8702-3 · Cited by 789
Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis
Mease, P. J., McInnes, I. B., Kirkham, B., Kavanaugh, A., Rahman, P., van der Heijde, D., Landewé, R., Nash, P., Pricop, L., Yuan, J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1412679 · Cited by 746
Baeten, D., Baraliakos, X., Braun, J., Sieper, J., Emery, P., van der Heijde, D., McInnes, I., van Laar, J. M., Landewé, R., Wordsworth, P., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61134-4 · Cited by 595
Self-citationMease, P. J., van der Heijde, D., Ritchlin, C. T., Okada, M., Cuchacovich, R. S., Shuler, C. L., Lin, C.-Y., Braun, D. K., Lee, C. H., & Gladman, D. D. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209709 · Cited by 580
The pathogenesis of psoriatic arthritis
Veale, D. J., & Fearon, U. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30830-4 · Cited by 576
The IL-23-IL-17 axis in inflammatory arthritis
Lubberts, E. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.53 · Cited by 442
Nash, P., Kirkham, B., Okada, M., Rahman, P., Combe, B., Burmester, G.-R., Adams, D. H., Kerr, L., Lee, C., Shuler, C. L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31429-0 · Cited by 405
IL-17 in Chronic Inflammation: From Discovery to Targeting
Beringer, A., Noack, M., & Miossec, P. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.01.001 · Cited by 402
The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
Liu, T., Li, S., Ying, S., Tang, S., Ding, Y., Li, Y., Qiao, J., & Fang, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.594735 · Cited by 386
van der Heijde, D., Cheng-Chung Wei, J., Dougados, M., Mease, P., Deodhar, A., Maksymowych, W. P., Van den Bosch, F., Sieper, J., Tomita, T., Landewé, R., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31946-9 · Cited by 370
Self-citationInterleukin-17 and innate immunity in infections and chronic inflammation
Isailovic, N., Daigo, K., Mantovani, A., & Selmi, C. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.04.006 · Cited by 363
Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview
Schinocca, C., Rizzo, C., Fasano, S., Grasso, G., La Barbera, L., Ciccia, F., & Guggino, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.637829 · Cited by 360
Ankylosing spondylitis: an autoimmune or autoinflammatory disease?
Mauro, D., Thomas, R., Guggino, G., Lories, R., Brown, M. A., & Ciccia, F. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00625-y · Cited by 353
McInnes, I. B., Sieper, J., Braun, J., Emery, P., van der Heijde, D., Isaacs, J. D., Dahmen, G., Wollenhaupt, J., Schulze-Koops, H., Kogan, J., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202646 · Cited by 343
Self-citationRuiz de Morales, J. M. G., Puig, L., Daudén, E., Cañete, J. D., Pablos, J. L., Martín, A. O., Juanatey, C. G., Adán, A., Montalbán, X., Borruel, N., et al. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.102429 · Cited by 338
Self-citationMenon, B., Gullick, N. J., Walter, G. J., Rajasekhar, M., Garrood, T., Evans, H. G., Taams, L. S., & Kirkham, B. W. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38376 · Cited by 293
Braun, J., Baraliakos, X., Deodhar, A., Baeten, D., Sieper, J., Emery, P., Readie, A., Martin, R., Mpofu, S., & Richards, H. B. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209730 · Cited by 273
Self-citationKenna, T. J., Davidson, S. I., Duan, R., Bradbury, L. A., McFarlane, J., Smith, M., Weedon, H., Street, S., Thomas, R., Thomas, G. P., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33507 · Cited by 262
β‐glucan triggers spondylarthritis and Crohn's disease–like ileitis in SKG mice
Ruutu, M., Thomas, G., Steck, R., Degli‐Esposti, M. A., Zinkernagel, M. S., Alexander, K., Velasco, J., Strutton, G., Tran, A., Benham, H., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34423 · Cited by 262
Update on Ankylosing Spondylitis: Current Concepts in Pathogenesis
Smith, J. A. (2015) · Current Allergy and Asthma Reports · doi:10.1007/s11882-014-0489-6 · Cited by 257
McGonagle, D. G., McInnes, I. B., Kirkham, B. W., Sherlock, J., & Moots, R. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215356 · Cited by 254
Reinhardt, A., Yevsa, T., Worbs, T., Lienenklaus, S., Sandrock, I., Oberdörfer, L., Korn, T., Weiss, S., Förster, R., & Prinz, I. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39732 · Cited by 219
Metadata
- Authors
- Noordenbos, T., Yeremenko, N., Gofita, I., van de Sande, M., Tak, P. P., Caňete, J. D., & Baeten, D.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2011-12-29
- Volume
- 64
- Issue
- 1
- Pages
- 99-109
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W1964722637
- Cited by
- 270
- References
- 44
- FWCI
- 17.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.